News
2019/December
The Laboratory of Functional Genetics has been awarded a 2 years research credit (CDR) from the FRS-FNRS in order to analyze the role of the phosphoinositides 5-phosphatase Inpp5k in T cells.
2019/July
The Laboratory of Functional Genetics has been awarded a 2 years research credit (CDR) from the Université de Liège in order to analyze the role of Inpp5k in hematopoietic cells.
2018/December
The Laboratory of Functional genetics has been awarded a 2 years research credit (CDR) from the Université de Liège in order to analyze the role of Ship2/Inppl1 in endochondral ossification and in murine opsismodysplasia.
2017/December
Bastien Moes, who graduated in 2016 from the Faculty of Sciences/Biochimie-Biologie Moléculaire et Cellulaire of the Université de Liège, obtained a 4-year FRIA grant from the FRS-FNRS to perform a PhD thesis in the Laboratory of Functional Genetics on the role of Inpp5K in B cells and B-ALL.
2017/December
The Laboratory of Functional Genetics has been awarded a 2 years research credit (CDR) from the Université de Liège in order to analyze the role of Inpp5K in hematopoietic cells.
2017/December
The Laboratory of Functional Genetics has been awarded a 2 years research credit (CDR) from the FRS-FNRS in order to analyze the role of Inpp5K in B cells.
2015/December
The Laboratory of Functional Genetics has been awarded a 2 years research credit (CDR) from the FRS-FNRS in order to analyze the role of Ship2/Inppl1 in the kidney.
2015/December
Charles-Andrew Vande Catsyne, who graduated in 2014 from the School of Veterinary Medicine of the Université de Liège, obtained a 3-year FRIA grant to perform a PhD thesis in the Laboratory of Functional Genetics on the role of Ship2/Inppl1 in Opsismodysplasia, a rare genetic skeletal dysplasia in man.
2015/November
Dr. Abdelhalim AZZI, who recently obtained his PhD from the University of Zurich/Switzerland for a work on the molecular mechanisms of plasticity in rythmic daily behavior (Azzi A et al., Nature Neurosciences 2014 17:377-382) received a 2-year BeIPD-Cofund grant in order to perform a post-doctoral stage in the Laboratory of Functional Genetics on phosphoinositides regulating enzymes.
2014/December
The Laboratory of Functional Genetics has been awarded a 4 years research project (PDF) grant from the FRS-FNRS, including a 1/2 technician position, in order to work on the role of Rasa3 in angiogenesis.
2012/June
The Laboratory of Functional Genetics has been awarded a 5 years ARC research grant starting in October 2012 and including post-doc positions. The research project is on the IP3 3-kinase Itpkc and its role in the immune system. The project is performed in close collaboration with Prof. F. Bureau's team at the GIGA Research Centre.
2011/December
The Laboratory of Functional Genetics has been awarded a 4 years FRSM research grant from the FRS-FNRS, including a post-doc position, in order to work on the 5-phosphatase Inpp5k.
2011/March
The Laboratory of Functional Genetics has been awarded a 2 years research grant from the Université de Liège, in order to work on the 5-phosphatase Inpp5k.
2010/December
The Laboratory of Functional Genetics has been awarded a 4 years WELBIO grant. WELBIO - Walloon Excellence in Lifesciences and Biotechnology - is a new virtual institute for excellence in basic health research in Wallonia. The granted research will focus on the analysis of a new tumor suppressor gene in mouse and man. It is intended to result in the identification of a new biomarker/drug target for cancer.
2010/September
The Laboratory of Functional Genetics has been awarded a 2 years STARTING grant from the Université de Liège, in order to work on Rasa3.
2011
The Laboratory of Functional Genetics was founded in 2011 by Stéphane Schurmans. The lab is located in the GIGA Centre, the Research Centre of Excellence of the Université de Liège, and is integrated in the CHU Academic Hospital.
The GIGA Centre is a unique organizational structure which offers a novel concept of open laboratories, shared equipments and high quality technology platforms, favoring multidisciplinary and collaborations between research teams.
The GIGA technology platforms result from the pooling of technological and human resources to offer state-of-the art technology and to adequately meet the needs of the researchers. Each technology platform is managed by a scientist and an academic researcher and offers services to researchers. The technology platforms include Proteomics, Transcriptomics, Genetics/Sequencing, Imaging/Flow Cytometry, Bioinformatics, mouse and zebrafish transgenics, Histology and a Biobank.
